scholarly article | Q13442814 |
P356 | DOI | 10.1210/EN.2017-00416 |
P8608 | Fatcat ID | release_lwtleq6ambgjxlgpapwzyld5ii |
P932 | PMC publication ID | 5659692 |
P698 | PubMed publication ID | 28977602 |
P2093 | author name string | James R Sowers | |
Bysani Chandrasekar | |||
Gerald A Meininger | |||
Ravi Nistala | |||
Annayya R Aroor | |||
Vincent G DeMarco | |||
Cassandra E Smith | |||
Shawn B Bender | |||
Scott M Brown | |||
Alex I Meuth | |||
Maloree Khan | |||
Hannah M Cleeton | |||
P2860 | cites work | Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes | Q82787527 |
Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction | Q83285665 | ||
Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α | Q86488169 | ||
Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice | Q86916012 | ||
Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart | Q87349316 | ||
Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains | Q87457408 | ||
Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats | Q89156034 | ||
Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling | Q22009382 | ||
Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 | ||
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase | Q24290148 | ||
Act1, an NF-kappa B-activating protein | Q24654030 | ||
Diabetic cardiomyopathy: bench to bedside | Q26997062 | ||
Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure. | Q27340146 | ||
Trends in prevalence and outcome of heart failure with preserved ejection fraction | Q28252937 | ||
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus | Q28297680 | ||
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice | Q33644666 | ||
Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice | Q33750640 | ||
Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4. | Q33902466 | ||
Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity | Q34027687 | ||
Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system | Q34062829 | ||
Application of atomic force microscopy measurements on cardiovascular cells | Q34119818 | ||
Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor | Q34219918 | ||
Ectonucleotidase CD38 demarcates regulatory, memory-like CD8+ T cells with IFN-γ-mediated suppressor activities | Q34428428 | ||
N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats | Q34554693 | ||
Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology | Q35175554 | ||
Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness | Q35390440 | ||
Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus | Q35411329 | ||
Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice | Q35738015 | ||
Regional variation in arterial stiffening and dysfunction in Western diet-induced obesity. | Q35958598 | ||
Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro | Q36096985 | ||
Endothelial Mineralocorticoid Receptors Differentially Contribute to Coronary and Mesenteric Vascular Function Without Modulating Blood Pressure | Q36143316 | ||
Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells | Q36229116 | ||
Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis | Q36289289 | ||
Role of angiotensin II in the evolution of diastolic heart failure | Q36332211 | ||
CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy | Q36337179 | ||
CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction. | Q36711861 | ||
CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis | Q36882248 | ||
Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats | Q36946065 | ||
Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration | Q36957712 | ||
Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure | Q37090864 | ||
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. | Q37258157 | ||
Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. | Q37387706 | ||
An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease | Q38053516 | ||
Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling | Q38380871 | ||
Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial | Q38424163 | ||
Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review | Q38592514 | ||
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system | Q38751579 | ||
Role of bone marrow-derived CD11c+ dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy | Q38872059 | ||
Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling | Q39039959 | ||
Understanding memory CD8+ T cells | Q39169186 | ||
Regular Exercise Reduces Endothelial Cortical Stiffness in Western Diet-Fed Female Mice. | Q39443264 | ||
Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction | Q39514603 | ||
Excessive Adventitial Remodeling Leads to Early Aortic Maladaptation in Angiotensin-Induced Hypertension. | Q40241638 | ||
Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes | Q40534109 | ||
Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine | Q40580301 | ||
Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin αVβ3/nuclear factor-κB/interleukin-6 axis. | Q40665021 | ||
Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction. | Q41049541 | ||
Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis | Q41186913 | ||
Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure. | Q42050075 | ||
Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension | Q42784122 | ||
Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure | Q47959283 | ||
Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2. | Q48078654 | ||
MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway | Q50990734 | ||
Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? | Q51033306 | ||
Cutting edge: programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells. | Q51050277 | ||
Stimulation of T-Cell activation by CXCL12/stromal cell derived factor-1 involves a G-protein mediated signaling pathway. | Q52011943 | ||
Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats. | Q53022208 | ||
Depletion of CD8+ T Cells Exacerbates CD4+ T Cell-Induced Monocyte-to-Fibroblast Transition in Renal Fibrosis. | Q53207921 | ||
Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats. | Q53520949 | ||
Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy. | Q54215442 | ||
Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life. | Q54423601 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | diastole | Q492905 |
Diastolic function | Q30314111 | ||
P304 | page(s) | 3592-3604 | |
P577 | publication date | 2017-10-01 | |
P1433 | published in | Endocrinology | Q3054009 |
P1476 | title | Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice | |
P478 | volume | 158 |